Related Experiment Video
Updated: Jun 15, 2026

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
Use of In Vitro-In Vivo Correlation (IVIVC) to facilitate the development of polymer-based controlled release
1Biopharmaceutics Research and Parenteral Delivery, Pharmaceutical R&D, Merck & Co., West Point, PA 19486-0004, USA. amitava_mitra@merck.com
Abstract:
In Vitro-In Vivo Correlation (IVIVC) is being increasingly used to predict bioperformance of dosage forms without conducting animal and/or human studies which are not only time-consuming and expensive but also might be considered ethically undesirable. The main aim of IVIVC methods is to develop in vitro drug release methods which are simple, robust, reproducible, inexpensive, in compliance with compendial and regulatory requirements and finally can be used in lieu of in vivo studies to direct formulation selection. This review provides a summary of currently marketed polymeric depot products and the patents related to these drug delivery systems in addition to currently available in vitro release methods used to study drug release from injectable controlled release drug delivery systems, currently available IVIVC methods and some examples of successful IVIVC for small molecules, peptides and proteins formulated in controlled release formulations administered subcutaneously or intramuscularly.
Related Concept Videos
Drug Product Performance: In Vitro–In Vivo Correlation
In Vitro Drug Release Testing: Overview, Development and Validation
In Vitro Drug Dissolution: Alternative Methods
In Vitro Drug Dissolution: Compendial Testing Models I
In Vitro Drug Dissolution: Compendial Testing Models II
Modified-Release Drug Delivery Systems: Rate-Programmed I

